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ABSTRACT Fluorescence dipolar resonance energy transfer between a receptor-bound fluorescent agonist, dansyl-C6-
choline, and two membrane-partitioned fluorescent probes, C18-rhodamine and C12-eosin, was used to measure the transverse
distance between the acetylcholine (ACh) binding sites on the intact Torpedo nicotinic acetylcholine receptor (nAChR) and the
surface of the lipid membrane. Control experiments demonstrated that: (1) dansyl-C6-choline binds to cobra-a-toxin sensitive
sites on the nAChR with a KD 20 nM, (2) the quantum yield of dansyl-C6-choline increases 3.1-fold upon binding, and (3)
the receptor-bound dansyl-C6-choline fluorescence is stable for at least 2 h. The calculated transverse distances between
receptor-bound dansyl-C6-choline and the membrane-partitioned acceptors, C12-eosin and C18-rhodamine, were 31 and 39 A,
respectively. Therefore, given the dimensions of the extracellular domain of the receptor, the ACh binding sites are located
significantly below (-25 A) the extracellular apex of the nAChR. These results are in agreement with the recent proposed location
for the ACh binding sites in a pocket within each of the two a-subunits, -30 A above the membrane surface (Unwin, N. (1993)
J. Mol. Biol. 229: 1101-1124).
INTRODUCTION
The nicotinic acetylcholine receptor (nAChR) is a member
ofthe family of ion-gated channels that includes the GABAA,
glycine, and serotonin (5-HT3) receptors (Stroud et al.,
1990). The muscle-type nAChR isolated from the Torpedo
electroplax is the best characterized member of this family.
It is formed by four types of subunits denoted as a, ,B, y, and
5 in a stoichiometric ratio of 2:1:1:1, respectively. Agonists
and competitive antagonists bind to two sites/receptor func-
tional unit (Galzi, et al., 1991). The agonist-competitive an-
tagonist or acetylcholine (ACh) binding sites are primarily
formed by the two a-subunits (see Karlin, 1991, for a re-
view); however, the 6, y, and ,3 subunits appear to contribute
to the formation of the ACh binding sites (Chatrenet et al.,
1990; Pedersen and Cohen, 1990). In addition to the agonist/
competitive antagonist binding sites, there exists a class of
high-affinity noncompetitive inhibitor (HNCI) binding sites
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that are generally thought to be located in the transmembrane
domain of the receptor (Taylor et al., 1991). Many organic
cations can interact with both classes of binding sites if
present in sufficiently high concentrations.
The location of the ACh binding sites relative to the qua-
ternary structure of the nAChR has been investigated by
using various approaches. Electron microscopic studies of
membrane-associated nAChR (Klymkowsky et al., 1979;
Zingsheim et al., 1982) or tubular crystals of nAChR
(Kubalek et al., 1987) and x-ray diffraction studies (Kistler
et al., 1982; Mitra et al., 1989) suggest that the competitive
antagonist, a-bungarotoxin, binds at the extracellular apex of
the receptor. Fluorescence resonance energy transfer (FRET)
measurements, on the other hand, point to a location of the
ACh binding sites significantly below the extracellular apex.
The distance between the ACh binding sites and the HNCI
binding site for ethidium was found to be only 21-40A (Herz
et al., 1989). Given that 1) ethidium is a voltage-dependent
channel blocker that probably binds to the transmembrane
region of the receptor (Sterz et al., 1982; Herz et al., 1987,
1991, 1992), and 2) the receptor protrudes 55-65 A out of
the extracellular side of the membrane (Kistler et al., 1982;
Toyoshima and Unwin, 1990), this FRET study suggests that
the ACh binding sites are located -22-45 A below the ex-
tracellular apex of the nAChR.
Similarly, Johnson et al. (1990) measured with FRET the
distance from sites of fluorescein labeling on receptor-bound
cobra-a-toxin to the membrane surface. The calculated trans-
verse distance between these sites on the cobra-a-toxin and
the membrane surface ranged between 39 and 45 A. Given
the size of the a-toxin (20 X 30 X 40 A (Walkinshaw et al.,
1980)) and its deduced orientation on the nAChR (Johnson
et al., 1990), the ACh binding sites would appear to be lo-
cated -30A above the membrane surface, and therefore well
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below the extracellular apex. However, the lack of confir-
mation of the proposed orientation of the bound cobra-a-
toxin (Johnson et al., 1990) necessitates the use of an ap-
proach that is independent of the a-toxin orientation.
Toward this end, we report here the use of a relatively
small fluorescent nicotinic agonist, dansyl-C6-choline, as an
electronic energy donor to two membrane-partitioned accep-
tors, octadecyl rhodamine B (C18-rhodamine) and 5-(N-do-
decanoyl)aminoeosin (C12-eosin). These acceptors are com-
posed of a charged fluorophore attached to a hydrocarbon
membrane anchor. With such a molecular configuration
these probes would be expected, upon partitioning into mem-
branes, to position themselves at the water-lipid interface
and, thus, allow transverse distance measurements between
the agonist sites and the surface of the lipid membrane.
EXPERIMENTAL PROCEDURES
Materials
5-(N-Dodecanoyl)aminofluorescein (C12-fluorescein), C12-eosin, and C18-
rhodamine were purchased from Molecular Probes (Eugene, OR). Torpedo
californica electric rays were obtained from Marinus Inc. (Long Beach,
CA). Phencyclidine (PCP) and suberyldicholine were from Sigma (St.
Louis, MO). Cobra-a-toxin was isolated following the method of Karlsson
et al. (1971) from Naja naja siamensis venom purchased from the Miami
Serpentarium (Salt Lake city, UT). Dansyltrimethylamine perchlorate was
acquired from Pierce Chemical Co. (Rockford, IL).
Receptor isolation
Nicotinic acetylcholine receptor-enriched membranes, designated below as
nAChR membranes, were isolated from T. californica electric organ by
established procedures (Johnson and Yguerabide, 1985). The receptor-
specific activities were determined by the decrease in dansyltrimethylamine
(6.6 ,M) fluorescence produced by the titration of suberyldicholine into
receptor suspensions (0.3 mg of protein/ml) in the presence of PCP (100
,uM), following the method of Neubig and Cohen (1979). The receptor-
specific activities ranged between 1.2 and 1.4 nmol/mg of protein.
Synthesis of dansyl-hexanoic acid
5-Dimethylaminonaphthalene-l-sulfonyl chloride (dansyl chloride, 3.7
mmol) in 80 ml of methanol was slowly added to 80 ml of recrystallized
6-aminohexanoic acid (3.7 mmol) in aqueous sodium carbonate (0.8 M).
The reaction mixture was incubated for 10 h at -40°C with continuous
stirring and the pH maintained at 9.5 by small additions of sodium carbonate
(2.5 M). The reaction mixture was then rotary evaporated, suspended in - 10
ml of ammonium bicarbonate (0.1 M), and applied to a C18 reversed-phase
flash chromatography (Baker cat. no. 7025-0) column (15 X 3 cm) equili-
brated with 0.1 M aqueous ammonium carbonate. The column was sequen-
tially washed with 500 ml each of H20, H20:CH3OH (4:1, v/v), H20:
CH30H (2:1, v/v), and H20:CH3OH (1:1, v/v). The fractions associated with
the 2:1 H20:CH3OH wash, that contained the desired product, were rotary
evaporated to near dryness and lyophilized. The final product was 1.03 g
of a yellow powder (3.0 mmol, 73% yield).
Synthesis of dansyl-C6-choline
Dansyl-hexanoic acid (1.3 mmol) was treated with N,N-carbonyl-
diimidazole (2.7 mmol) in 5 ml of anhydrous N,N-dimethylformamide at
room temperature until cessation of CO2 production. N,N-Dimeth-
ylethanolamine (2.3 mmol), that had been previously treated with -60 mg
of sodium metal, was added to the reaction mixture and incubated for 16
h at 65°C under N2. The reaction mixture was placed on ice and iodomethane
(2 mmol) was added. After 30 min, the reaction mixture was rotary
evaporated, dissolved in 5 ml of ethanol, and eluted through an anion ex-
change (AG-1-X2) column (2 X 2 cm) (1 ml/min) equilibrated in ethanol.
The fluorescent fractions were rotary evaporated to yield 1.35 g of a yel-
low oil (2 mmol, 77% yield). Electrophoresis of the product showed mi-
gration of a single fluorescent spot toward the negative pole at both pH
7.0 and 11.0. Silica gel thin layer chromatography (CHCl3:CH30H:
CH2COOH:H2O, 25:12:4:2, v/v) of the product indicated a single fluores-
cent spot with an Rf = 0.18.
Fluorescence measurements
Steady-state fluorescence measurements were made with an MPF 66 spec-
trofluorometer (Perkin-Elmer Cetus). Emission correction factors were gen-
erated with the aid of a calibrated 150-watt reference lamp from Optronics
Laboratories (Orlando, FL). Fluorescence lifetimes were determined by the
time-correlated single photon-counting technique using a nanosecond fluo-
rescence spectrofluorometer (EEY scientific; La Jolla, CA), equipped with
a high pressure hydrogen arc lamp.A Polaroid HNPB dichroic film polarizer
(Norwood, MA), rotated 550 relative to the vertical, was placed in the emis-
sion path, and fluorescence decays were analyzed with the GLOBALS UN-
LIMIT'ED program (version 1.01; Fluorescence Dynamics Laboratory;
Urbana-Champaign, IL).
Affinity of specific dansyl-C6-choline binding to
nAChR-enriched membranes
The equilibrium dissociation constant of dansyl-C6-choline was estimated
by the forward titration of dansyl-C6-choline into nAChR suspensions (50
nM in suberyldicholine binding sites) in buffer I, previously incubated with
PCP (40 AuM). A parallel sample that was preincubated for 30 min at room
temperature with cobra-a-toxin (200 nM) assessed the fluorescence from
nonspecifically bound dansyl-C6-choline. The binding affinities were es-
timated by fitting plots of the specific fluorescence associated to dansyl-
C6-choline binding to the ACh binding site (cobra-a-toxin-sensitive fluo-
rescence) versus the total ligand concentration to a four-parameter logistic
equation (sigmoid) by using the GraphPad computer program (GraphPAD
Software; San Diego, CA).
Fractional specific and nonspecific
dansyl-C6-choline association with the nAChR
membranes
Dansyl-C6-choline (0.4 ,uM) and nAChR membranes (0.4 ,uM in suberyl-
dicholine binding sites) were suspended in 1.5 ml of buffer I and PCP (100
,uM), with and without cobra-a-toxin (4 ,uM). Parallel samples that con-
tained equivalent concentrations of dansyl-C6-choline in buffer I or nAChR
membranes suspended in buffer I, both in the presence of PCP, were used
to determine the total and background fluorescence, respectively. The
samples were centrifuged in a Beckman TL-100 ultracentrifuge at 100,000
g for 1 h. at room temperature and the supernatant-dansyl-C6-choline emis-
sion was monitored at 550 nm with excitation at 220 nm. In the absence of
specific binding the apparent membrane partition coefficient (Kp) of dansyl-
C6-choline was calculated with the expression
I - IS L
* _ total -+tox pKp- is L
+tox LF
(1)
where I is the background-subtracted dansyl fluorescence. The superscript
S represents the fluorescence of the supernatants, and the subscripts total
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and +tox represent the samples that contained only the fluorophore in
buffer, fluorophore + nAChR membranes + a-toxin, and nAChR only,
respectively. LP and LF are the amounts of ligand membrane-partitioned and
free, respectively.
The fraction of the dansyl-C6-choline that specifically binds to the ACh
binding sites (fB) was calculated with the expression
itotal -itox (1 + KP*) LB
fB= Litotal LT
(2)
where Is-tox is the background-subtracted supernatant fluorescence of the
samples that contained both fluorophore and nAChR but not a-toxin. LB and
LT are the amounts of specifically bound and total ligand, respectively.
Quantum yield of nAChR-bound and
membrane-partitioned dansyl-C6-choline
The quantum yield of dansyl-C6-choline bound to the nAChR (QB) was
determined by solving Eq. 3 (see Appendix for derivation) for QB.
QB= (QF + KPQP) (VLt../I+t.) + fB - 1)fB (1+Kp*) (3)
where L_t.0I+ t. is the ratio of the dansyl-C6-choline fluorescence intensities
in the absence and in the presence of cobra-a-toxin, and Qp is the quantum
yield of membrane partitioned dansyl-C6-choline. The Qp of dansyl-C6-
choline was determined with Eq. 4
QPIQF =IP/IF (4)
where the QF is the quantum yield of free dansyl-C6-choline, and Ip and IF
are the fluorescence intensities of membrane partitioned and free dansyl-
C6-choline, respectively. (Here, it is assumed that the emission and ab-
sorption spectra of the partitioned and free dansyl-C6-choline are the same.)
The QF was determined by the ratio method of Chen et al. (1965) with
fluorescein in 0.1 N NaOH as a standard. IF was measured directly by using
a cuvette that contained dansyl-C6-choline (0.4 ,M) in buffer I. The Ip was
determined from a cuvette that contained PCP (100 ,uM), dansyl-C6-choline
(0.4 ,uM), cobra-a-toxin (4 ,uM), and nAChR membranes (0.4 ,uM in su-
beryldicholine binding sites) suspended in buffer I. A sample that contained
identical concentrations ofnAChR membranes, PCP, and cobra-a-toxin was
used to subtract the background fluorescence. The background-subtracted
fluorescence (Iobs) was corrected for inner filter effects (I r) produced by
the light scattering from the membrane fragments, with Eq. 5 (Lakowicz,
1983)
I, = Iobs 2.303 exp[(OD, + ODe,m)/2] (5)
where ODex and ODem are the absorbance of the sample at 310 and 540 nm,
the excitation and emission wavelengths used to monitor the dansyl-C6-
choline fluorescence.
Fluorescence resonance energy transfer (FRET)
model
To calculate the transverse distance between the receptor-bound donors
and acceptors randomly positioned at the membrane surface we used the
Off-Axis model that assumes that the donors are attached at a distance 8
from the major axis of symmetry of cylindrical proteins imbedded into a
planar-lipid membrane. The symmetry axis of this protein is perpendicu-
lar to the membrane surface. The transverse distance from the protein-
bound donors to acceptors positioned in the plane of the water-lipid inter-
face is Rp. The distance of closest approach between the acceptors and
the central axis of the protein in the acceptor plane is a, and a is assumed
to be greater than or equal to 8. All this is represented graphically in Fig.
1. This model is derived in a more general form elsewhere (see accompa-
nying article by Yguerabide ).
FIGURE 1 Schematic representation of the Off-Axis membrane FRET
model. (A) Schematic representation in the acceptor plane of the coordi-
nate system used to describe the position of an acceptor A relative to the
projection of the donor (D') into the acceptor plane. The radius a of
the circle is the distance of closest approach of acceptors to the center of
the circle C. The center is the point where the transverse symmetry axis S
of the cylindrically symmetric protein intercepts the acceptor plane. 8 is
the distance from the symmetry axis S at the center of the circle to D'.
The position of A with respect to D' in the acceptor plane is described by
the distance R and angle 0. (B) Cross-sectional representation of this
model. r is the distance of closest approach between the donor D and an
acceptor A. Membrane-partitioned acceptors are assumed to be distrib-
uted randomly in a planar array at a distance Rp below the level of the
donors.
To calculate theoretical energy transfer efficiency for this model, the
fluorescent lifetime of the donor is represented by TD. The donor fluores-
cence intensity, F(t), at any time t after excitation by a very short pulse of
light is given by
F(t) = F(0)e-t/TDe -£M(t) (6)
where ar is the surface density of acceptors and M(t), in turn, is defined by
the following integral
M(t) = 2 S(t, 0) dO.
S(t, 0) is given by the integral
S(t, 0) = (1 - e(t/l)(Ro/r)6)r dr
rc(0)
(7)
(8)
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where r is the distance between donor-acceptor pairs and rr is the distance
of closest approach between donor-acceptor pairs and equals
rc(O) = [RI + R'(0)]1 (9)
where
Rc(O) =-8 COS 0 + [82COS20 + (a2 82)]1/2. (10)
For steady-state emission, the ratio of donor fluorescence in the presence
over absence of acceptor (ID/IDA) is given by the integral ratio
ID C0 FD(t) dt (11)
IDA fOmFDA (t)dt
where the subscriptsD andDA denote the absence and presence of acceptor,
respectively. The surface density of acceptor probes was determined as
described in Valenzuela et al., (1992).
FRET measurements
Dansyl-C6-choline (0.4 ,uM) and nAChR-associated membranes (0.4 J,M in
suberyldicholine binding sites) were suspended in buffer I, in the presence
of PCP (100 ,M). The excess PCP was added to prevent dansyl-C6-choline
from binding to the HNCI site, thereby increasing the specificity of the
dansyl-C6-choline binding. A parallel cuvette that also contained cobra-a-
toxin (4 ,uM) was used to estimate the fluorescence of the nonspecifically
bound dansyl-C6-choline. Titrants were dissolved in dimethyl sulfoxide
(which had no measurable effect on dansyl-C6-choline fluorescence) and
were added to the cuvettes with Hamilton syringes. After each addition of
titrant, the samples were incubated for 5 min before fluorescence mea-
surements were performed. Initial control experiments demonstrated that
the titrants were at equilibrium with the membrane within 5 min. (data
not shown). All samples were corrected for intrinsic fluorescence of the
acceptors and background fluorescence, as previously described by
Valenzuela et al. (1992).
Because only a fraction of the dansyl-C6-choline (fB = 0.85) was spe-
cifically bound to the ACh binding sites, the determination of the specific
FRET to the membrane-partitioned acceptors required separation of the
bound donor fluorescence (IB) from the free and membrane-partitioned do-
nor fluorescence. This was accomplished by using Eq. 12.
(12)IB -Itox (1 B)I+t.x
where '-tox and I+tox are the magnitudes of fluorescence of samples that did
not or did contain cobra-c-toxin, respectively (see Appendix for derivation).
The observed fluorescence was corrected for dilution and inner filter effects
of the acceptor. The fraction of dansyl-C6-choline that was not bound to the
ACh binding sites (1 - fB) was determined with the centrifugation assay
described above.
For the FRET experiments, the dansyl-C6-choline was excited at 310 nm
instead of 340 nm for direct excitation or 280 nm for indirect-dansyl ex-
citation through the receptor tryptophans. This was done both to enhance
receptor-bound dansyl-C6-choline fluorescence (310-nm excitation yields
about 50% greater receptor-bound dansyl fluorescence than 340 nm), and
to avoid indirect excitation of dansyl via a FRET process between receptor
tryptophans and receptor-bound dansyl-C6-choline. FRET between receptor
tryptophans and dansyl-C6-choline was avoided, because the lipophilic ac-
ceptors used directly quench nAChR tryptophans fluorescence (unpublished
observation) and, thereby, indirectly quench receptor-bound dansyl-C6-
choline fluorescence. Indirect tryptophan-to-dansyl excitation inappropri-
ately enhances the dansyl-C6-choline quenching. Evidence that 310-nm ex-
citation does not produce significant indirect tryptophan-to-dansyl
excitation comes from the fact that the dansyl-C6-choline fluorescence in the
absence of cobra-a-toxin divided by its fluorescence in the presence of the
toxin (Lt0X/I+t.X) is essentially the same whether or not the samples are
excited at 310 nm (ILt.,/I+t.. = 2.1 + 0.4; 13 determinations) or 340 nm
(I-toxII+tox = 2.3 ± 0.6; seven determinations). Excitation at 280 nm is
associated with 6.9 ± 0.5 fold (four determinations) increase in dansyl-
C6-choline fluorescence (data not shown).
RESULTS
Kd for dansyl-C6-choline binding to the ACh sites
The concentration-dependent change in dansyl-C6-choline
fluorescence that is associated with its binding to the ACh
binding sites (cobra-a-toxin-sensitive fluorescence) is
shown in Fig. 2. A nonlinear fit of this data to a four-
parameter logistic equation (sigmoid) yielded a Kd of 20 +
14 nM. This value is in reasonable agreement with the Kd =
10 nM measured by the decrease in the initial velocity of
[3H]a-toxin binding to receptor-enriched microsacs
(Heidmann and Changeux, 1979a).
Fractional specific and nonspecific association of
dansyl-C6-choline with nAChR membranes
Following centrifugation of samples containing dansyl-C6-
choline and nAChR membranes, the background-subtracted,
supernatant-dansyl fluorescence was reduced by 88 ± 2%
when compared to samples that did not contain nAChR mem-
branes (Table 1). When cobra-a-toxin was preincubated in
parallel samples, supernatant-dansyl fluorescence was only
reduced 19 ± 3% (Table 1). Because the total volumes of
membranes and solvent remained constant, the ratio of
membrane-partitioned/free dansyl-C6-choline should remain
constant with and without cobra-a-toxin. Consequently, un-
der the conditions in which the FRET experiments (described
below) were performed, the fraction of dansyl-C6-choline
that was specifically bound to the ACh binding sites was
(fB =) 0.85 (Eq. 2), and the apparent partition coefficient
(Kp) of dansyl-C6-choline was calculated (Eq. 1) to be 0.24.
This means that when dansyl-C6-choline is allowed to bind
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FIGURE 2 Concentration dependence of specific dansyl-C6-choline
binding to the nAChR. Incremental amounts of dansyl-C6-choline were
titrated into suspensions of nAChR (50 nM in suberyldicholine binding
sites) previously incubated for 10 min with PCP (40 AM), in the absence
and in the presence of an excess of cobra-a-toxin (200 nM). The numerical
difference between the samples without and with a-toxin (average of nine
determinations ± standard deviation) is plotted and represents the cobra-
a-toxin sensitive fluorescence, which is associated with dansyl-C6-choline
binding to the ACh binding sites. The excitation and emission wavelength
were 280 and 540 nm, respectively. The Kd value was 20 ± 14 nM and the
Hill slope was 1.7 ± 0.6. The solid line was drawn using the best fit pa-
rameters to a four-parameter logistic equation (sigmoid).
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TABLE 1 Specific and nonspecific association of dansyl-C6-choline to the nAChR membranes
Dansyl-C6-choline + Dansyl-C6-choline +
Dansyl-C6-choline + PCP PCP + nAChR PCP + nAChR + a-toxin
(Vtotal) (I-to.) (I+tox)
Supernatant fluorescence 245.1 ± 4.1 28.1 ± 6.6 198.0 ± 13.5
Shown is the background-subtracted dansyl fluorescence of the supematants of samples that contained dansyl-C6-choline (0.4 ,uM) and PCP (100 ,zM) ±
nAChR membranes (0.4 ,uM in suberyldicholine binding sites) and + cobra-a-toxin (4 ,M) suspended in buffer I and that were centrifuged at 100,000
g for 1 h. The dansyl fluorescence of the supematants was monitored at 550 nm with excitation at 220 nm. The results are the average ± SD of four
determinations.
to the receptor in the energy transfer experiments described
below, about 90% of the observed fluorescence is from
receptor-bound dansyl-C6-choline.
Energy transfer parameters
The quantum yield ofnAChR-bound dansyl-C6-choline (QB)
using Eq. 3 was calculated to be 0.22. This is essentially the
same value (0.21) obtained independently by multiplying
the ratio of fluorescence lifetimes of dansyl-C6-choline in the
presence to absence of nAChR membranes (8.6/3.0 ns) by
the quantum yield of dansyl-C6-choline in buffer I (0.073)
(data not shown). The spectral overlap between nAChR-
bound dansyl-C6-choline and the membrane acceptors, C12-
eosin and C18-rhodamine, is shown in Fig. 3. The absorption
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FIGURE 3 Spectral overlap of nAChR-bound dansyl-C6-choline and
C12-eosin or C18-rhodamine (membrane-partitioned acceptors). Shown are
the excitation spectra of the donor (-), excitation spectra of the acceptor
( * ), emission spectra of the donor (- --), and emission spectra of
the acceptor (. ). The donor is dansyl-C6-choline (100 nM). The accep-
tors (400 nM) are C12-eosin (panel A) and C18-rhodamine (B). All mea-
surements were made with nAChR-associated membranes (200 nM in su-
beryldicholine binding sites) that had been preincubated with PCP (100
,uM). A sample that contained an excess of cobra-ca-toxin (6 ,uM) and
dansyl-C6-choline (100 nM) was used to obtain the spectra of nonspecifi-
cally bound dansyl-C6-choline. These spectra were subtracted to obtain the
spectra of specifically bound dansyl-C6-choline. A cuvette that only con-
tained nAChR membranes was used to assess the background fluorescence
for the C18-rhodamine and C12-eosin samples.
spectra of the nAChR-partitioned membrane acceptors could
not be measured because of the turbidity of the samples.
Instead, the fluorescence excitation spectrum of the
membrane-associated fluorophores was used to represent the
spectral profile of the respective absorption spectrum. The
maximum extinction coefficients for C12-eosin and C18-
rhodamine were assumed equal to 85,000 and 94,000 cm-1
M-1, respectively (Haugland, 1992). The values of the
overlap integral for the dansyl-C6-choline/Cl8-rhodamine
and the dansyl-C6-choline/Cl2-eosin donor/acceptor pairs,
were 3.7 X 10-13 and 2.5 X 10-13 cm6/mol, respectively
(Table 2). The calculated Forster critical distances for the
two donor-acceptor pairs were 48 and 45 A, respectively.
Energy transfer between dansyl-C6-choline and
the lipid membrane probes
The concentration dependence of the uncorrected donor
quenching of nAChR-bound dansyl-C6-choline is shown in
Fig. 4. (Assuming that the lipid/probe ratio (w/w) of the
samples used for these experiments was 0.41 (Gonzalez-Ros
et al., 1982) and that the average molecular weight of the
nAChR membrane lipids is 800, then at the highest concen-
tration of probe used (6.8 p,M) the molar lipid/probe ratio
would be about 25:1.) The highest concentrations of C18-
rhodamine and C12-eosin produced about a 15 and 25% de-
crease in the uncorrected nAChR-bound dansyl-C6-choline
fluorescence, respectively. In the presence of cobra-a-toxin,
the highest concentrations of C18-rhodamine and C12-eosin
produced only about an 8 and 16% decrease in the fluores-
cence of nonspecifically bound dansyl-C6-choline, respec-
TABLE 2 Energy transfer parameters for the donor
dansyl-C6-choline and the membrane-partitioned acceptors
Cl8-rhodamine and C12-eosin
Acceptor J* (X1013) Rot Rp
cm6/mol A A
C18-rhodamine 3.7 48 39 ± 6
C12-eosin 2.5 45 31 ± 5
* Overlap integral equals XIB(A)EA(A))r4AIIB(AA where EA(X) is the
extinction coefficient of the acceptor. The quantum yield of receptor-bound
dansyl-C6-choline was determined as described under Experimental Pro-
cedures (QB = 0.22).
* Forster critical distance equals 9.765 X 103(QBnW4K2J)116 (assumptions:
K2 = 2 and n = 1.4).3§ Mean ± SD transverse distance to lipophilic fluorophores in membrane
calculated as described in Experimental Procedures (Eqs. 6-11).
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FIGURE 4 Effect of C18-rhodamine or C12-eosin on dansyl-C6-choline
fluorescence in the absence and in the presence of cobra-a-toxin. Plotted is
the fluorescence of nAChR-bound dansyl-C6-choline (l) as a function of
various concentrations of membrane-partitioned acceptors, C18-rhodamine
(A) or C12-eosin (B). The effect of the added C18-rhodamine or C12-eosin
on the fluorescence of samples that additionally contained nAChR-bound
cobra-a-toxin (; 4 ,uM) or that only contained nAChR (0) is also shown.
The concentrations of nAChR in suberyldicholine binding sites, dansyl-
C6-choline, and PCP were 0.4,0.4, and 100 ,uM, respectively. The excitation
wavelength was 310 nm (3-nm slit) in all cases. The emission wavelengths
were 500 and 540 nm for the experiments with C12-eosin and C18-
rhodamine, respectively. The emission slit was 5 nm in all cases. These
emission wavelengths were chosen to minimize the detection of acceptor
fluorescence. Corrections were made for dilution. Each datum point rep-
resents the average ± standard deviation of three determinations.
tively. The change in the fluorescence of the sample pro-
duced by the intrinsic fluorescence of the membrane-
acceptors was very small or insignificant.
The calculated (Eq. 12) nAChR-bound dansyl-C6-choline
fluorescence in the absence (QD) of acceptors was divided
by its fluorescence in the presence (QDA) of the acceptors,
C12-eosin or C18-rhodamine, and was plotted as a function
of the surface density of acceptors, a, times R2 (Fig. 5). For
comparison, theoretical plots of QD/QDA vs. o-R2 were cal-
culated numerically and are also shown for various values of
the transverse distance (Rp, with Eqs. 6-11). Analysis of the
slopes of the experimental data in relation to the theoretical
lines yielded Rp values of 39 and 31 A for the dansyl-C6-
choline/C18-rhodamine and the dansyl-C6-choline/Cl2-eosin
pairs, respectively (Table 2).
As a control to establish the stability of the receptor-bound
dansyl-C6-choline fluorescence, a suspension of the Torpedo
membranes and dansyl-C6-choline was prepared and moni-
tored for 2 h, the time to perform the FRET experiments
described above. No significant decrement of the dansyl-
C6-choline fluorescence was observed (data not shown).
DISCUSSION
In the present study, FRET techniques were used to esti-
mate the transverse distance between the two ACh binding
sites on the Torpedo nAChR and the surface of the lipid
membrane. The energy donor was dansyl-C6-choline, a
well characterized fluorescent agonist that binds with high
affinity (Kd 10-8 M) to the ACh binding sites on the
nAChR (Heidmann and Changeux, 1979a, b). Dansyl-C6-
choline, like other nicotinic agonists, depolarizes isolated
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FIGURE 5 Energy transfer between dansyl-C6-choline and the
membrane-partitioned C18-rhodamine and C12-eosin. Plotted as points ±
standard deviations (three determinations) are the average ratios ofnAChR-
bound dansyl-C6-choline (donor) fluorescence, in the absence (ID) and in
the presence (IDA) of the membrane-partitioned acceptors, C18-rhodamine
(El, A) or C12-eosin (U, B), as a function of the surface density of acceptors
(a) times the orRo. Plotted as a series of dotted lines are the numerically
calculated relation between ID/IDA and oR2 for discrete donors above a
planar distribution of acceptors with a transverse distance (Rp) ranging be-
tween 0-70 A (Eqs. 6-11; a = 8 = 27 A). The fluorescence of dansyl-
C6-choline bound to the nAChR was calculated with Eq. 8. The surface
density of acceptors (o-rR3, was determined as described under Experimental
Procedures. For more details see legend for Fig. 3.
electroplax from Electrophorus electricus and increases
22Na' efflux from receptor-enriched microsacs obtained
from Torpedo marmorata (Heidmann and Changeux,
1979a).
With dansyl-C6-choline as a donor, the average calculated
transverse distance between the ACh binding sites and the
chromophoric portions of C12-eosin or C18-rhodamine par-
titioned into the membrane was -35 A (illustrated in Fig. 6).
70 80 A
Dansyl1-C*Choiine
M -RhodnamineCor
Gyroe~ ~~2eo
FIGURE 6 Schematic representation of the location of the ACh binding
sites on the nAChR (following Unwin (1993)). Rp, the transverse distance
between the receptor-bound donor and the membrane-partitioned acceptors
positioned at the water-lipid interface, was found to be 30-39 A.
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This value is substantially less than the maximum extracel-
lular protrusion of the nAChR (55-65 A), and therefore sup-
ports the idea that the ACh binding sites are localized sub-
stantially below the apex of the extracellular protrusion of the
receptor. The recent 9-A resolution structural analysis of the
nAChR (Unwin, 1993) shows a pocket in about the center of
each a-subunit, -30 A above the surface of the membrane.
These pockets were postulated to correspond to the ACh
binding sites, which is consistent with the present finding that
the ACh binding sites are located -35 A above the mem-
brane surface. Clearly, more research is necessary to confirm
that the ACh binding sites are located in these pockets, be-
cause biochemical data indicate that the ACh sites are at
the a-,y and a-8 subunit interfaces (Chatrenet et al., 1990;
Pedersen and Cohen, 1990; Middleton and Cohen, 1991;
Czajkowski and Karlin, 1991; Czajkowski et al., 1993)
If the ACh binding sites are in these pockets, then struc-
turally complex arrangements of the extracellular domains of
one or more subunits would probably be required for the
formation of each ACh binding site. Consistent with struc-
turally complex ACh binding sites are affinity labeling (Kao
et al., 1984; Dennis et al., 1988; Abramson et al., 1989; Galzi
et al., 1990; Pedersen and Cohen, 1990; Cohen et al., 1991;
Middelton and Cohen, 1991) and site-directed mutagenesis
studies (Tomaselli et al., 1991) that demonstrate contribu-
tions from more than one segment of the NH2-terminal
extracellular domains of the a, 8, and -y subunits to the
formation of the ACh binding sites.
There are several issues that must be considered in the
interpretation of these findings. First, the model that was used
to analyze the FRET data assumes that there is a random
distribution of the membrane acceptors. If the lipophilic ac-
ceptors can differentially associate with the receptor, it
would lead to a nonrandom distribution of acceptors in the
membranes. Steroids and negatively charged fatty acids dis-
play 3-5-fold greater affinity for the receptor than the zwit-
terionic phosphatidylcholine (Ellena et al., 1983). It is rea-
sonable to expect that negatively charged C12-eosin and
positively charged C18-rhodamine differentially associate
with the receptor. However, despite possible differences in
the association of C12-eosin and C18-rhodamine to the re-
ceptor, the calculated distances of closest approach using two
differently charged acceptors were within -9 A of each
other, which illustrates that the method used is only weakly
dependent on the random distribution of the acceptors in the
membrane. Second, FRET studies usually are associated
with the problem of not knowing the orientation (K2) of the
donor-emission transition dipole relative to the acceptor-
absorption transition dipole. This is not a significant problem
in the experiments described in this manuscript, because the
energy transfer between energy donors and acceptors in-
volves both static and dynamic averaging (Dale et al., 1979;
Johnson et al., 1990). Moreover, although we used two ac-
ceptors which would presumably have different transition
dipole orientations, we still observed the same magnitude of
energy transfer to each acceptor after correcting for R2 and
In summary, our measurements suggest that theACh bind-
ing sites are located significantly below the extracellular
apex of the receptor, probably at a site equidistant from the
extracellular end and the beginning of the transmembrane
domain (Fig. 6). The FRET determinations presented above,
support the recently proposed location for the ACh binding
sites in two pockets, -30 A above the membrane surface
(Unwin, 1993), and should contribute to our understanding
of ligand-regulated gating of the nAChR and of other mem-
bers of this ion channel superfamily.
APPENDIX
When dansyl-C6-choline, L, can specifically bind to membrane-associated
receptors (LB > 0),
LT =LF +LP +LB (Al)
Introducing LB = LT * fB (see Eq. 2) into Eq. Al and solving for LF + LP
we get
(A2)LF + LP = (1 -fB)LT.
Introducing the expression
Kp*= Lp/LF
into Eq. A2 and solving for LF and LP gives
K*
Lp = 1 + K* (1- fB)LT
and
1
LF= 1-f)T
(A3)
(A4)
(A5)
When L is prevented from specifically binding to the receptor by the
presence of excess inhibitor (in the present case cobra-a-toxin), LB equals
zero and the total amount of ligand is equal to
LT=LF+LP. (A6)
Rearranging and substituting Eq. A3 into Eq. A6 and solving for LF and LP
gives
1
I= +K*L
P
and
K*
ApP1 + KPLT-
The steady-state fluorescence of LF equals
LF
IF= QFk -v
(A7)
(A8)
(A9)
where V is the sample volume, k is an instrument constant, E is the absor-
bance, and QF is the quantum yield of LF. The fluorescence of free L(IF) in
the absence of an excess of inhibitor (in this case cobra-a-toxin) can be
derived by substituting Eq. A5 into Eq. A9 and equals
1 LT
IF +K*~(' fB)QFkE-V (AlO)
(Here and below E is assumed to be the same when L is free, bound, or
membrane-partitioned.)
Similarly, in the presence of the inhibitor that prevents the specific bind-
ing ofL, the fluorescence of free ligand (IF) can be expressed by substituting
Eq. A7 into Eq. A9 and equals
LT
surface density.
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Similarly, the fluorescence of membrane partitioned ligand (Ip) in the
absence of inhibitor is given by substituting Eq. A4 into Eq. A9 in which
IF and LF are replaced with Ip and LT to yield
KP* LTIP 1+=K1 -fB)QPkE VT. (A12)
In the presence of inhibitor, the fluorescence ofmembrane partitioned ligand
(Ip) can be derived by substituting Eq. A8 into Eq. A9 in which IF and LF
are replaced with Ip and LT to give
KP LTIP 1 + Kp*Qe V*(A13)
Similarly, IB equals
LT
IB = fBQBke VL. (A14)
For samples that do not contain inhibitor, the total steady-state fluores-
cence ofL in the absence of an excess of a nonfluorescent inhibitor ('-tax)
is simply the sum of the fluorescence from bound, membrane-partitioned,
and free L. I-tox can, therefore, be represented as
IAQk LT (1- fB) Q LT ( Qk) LT (A15)
=fBk-v +(1 + Kp*) Qk-V+ (1 + Kp*) QFE-r A5
Similarly, in the presence of the inhibitor where there is no bound L, the
fluorescence ofL(I+t..) is only the sum of the fluorescence from membrane-
partitioned and free L and can be represented as
I+= l K QpkE 1+ lK QFkET (A16)
The rearrangement of Eq. A15 gives
B '-toxx 1 + K K k K*
The rearrangement of Eq. A16 gives
I+tOx(1 + Kp)
kELT/V p=KQP + QF (A18)
and the substitution of Eq. A18 into A17 gives
IB = I-t I+ox(1 - fB). (A19)
This shows that IB can be calculated without knowledge of the nonspecific
membrane-partitioning of the ligand or quantum yields of the ligand in
different microenvironments.
The quantum yield of the specifically bound ligand (QB) can be deter-
mined by taking the ratio of I-tax (Eq. A15) over I+tox (Eq. A16) and
rearranging to solve for QB giving
(QF+ KpQ[ItxIt)- 1+fB]QB= A (1+t x (A20)
We are grateful to Dfing Nguyen for assistance with the preparation of the
nAChR membranes.
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